Stay in touch

Prime news from our network.

#read

Saxony provides seven million euros for second biotech centre in Dresden

The Free State of Saxony has pledged around 6.71 million euros for the second Bioinnovation Centre in Dresden-Johannstadt (BIOZ II).
15/10/2023

New building is being constructed on the site of the former school administration office

The first bioinnovation centre, which opened in 2004,has been operating at full capacity for years. However, in order to facilitate further biotech settlements and spin-offs from the life sciences research institutes in Dresden, a new building is now being constructed on the site of the former school administration office in the immediate vicinity of the university hospital at a total cost of 18 million euros.

Martin Dulig sees great potential in the biotech sector

„Biotechnology, the healthcare industry and the life sciences sector are future technologies with great growth potential for the Free State of Saxony,

emphasised Economics Minister Martin Dulig (SPD). With the Max Planck Institute of Molecular Cell Biology and Genetics, the Max Bergmann Centre for Biomaterials, the Centre for Regenerative Therapies and the Biotechnology Centre of the TU Dresden, Dresden has a powerful complex of research institutions in these fields. Competitive spin-offs have emerged from these institutions in recent years. To ensure that this development continues, the Free State of Bavaria is supporting the expansion of the BIOZ.“

Better opportunities for biotech start-ups

The ministry announced that attractive office and laboratory space will be created on an area of over 4,000 square metres for start-ups and founder companies in the biotechnology sector. The option to rent such space is essential for the success of these companies," explained Dulig.

They cannot invest in building their own infrastructure during the start-up phase, nor can they wait a long time for rental options if they want to maintain their chances on the market.

Article from the "Oiger" of 15 October 2023

The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.

Click here to access the original content